Diagnostics

Latest developments in imaging biomarkers for dementia: PET-MRI scans

The EDoN initiative: Early Detection of Neurodegenerative diseases

PET-MRI and machine learning

Mass spectrometry-based proteomics identifies progressive changes in tau PTMs over time

Plasma p-Tau181 and p-Tau231 offer complementary information in Alzheimer’s

Diagnosing dementia in low educated and indigenous populations

Antibodies as research tools to study dementia

Microglia associated with longevity and a lower AD risk

The development of oligomer-specific antibodies and their potential use as a diagnostic tool

Hopes and challenges in AD research

The impact of antibodies use on biomedical research

The benefits of GWAS in understanding Alzheimer’s disease

Defining Alzheimer’s disease: clinical or biological

The role of phosphorylated tau in clinical trials

Using phosphorylated tau as a diagnostic tool for Alzheimer’s disease

Neurovascular dysfunction and Alzheimer’s disease pathology